The current situation of cancer morbidity and mortality in the light of the National Cancer Registry, Hungary.
Prostate ; — Molecular pathology of prostate cancer. Molecular subtypes and perspectives of targeted therapies in prostate cancer.
Molecular underpinnings of systemic treatment resistance in metastatic castration-resistant prostate cancer. Dvostruki navodi Integrative clinical genomics of advanced prostate cancer.
Cell ; — Germline and somatic mutations in prostate cancer for the clinician. J Natl Compr Canc Netw.
Kalina Ildikó dr. Summary The MRI scanners operating in our country with 1. PI-RADS has been elaborated in order to offer a simplified and standardized MRI reporting method in case of the prostate and to facilitate interdisciplinary communication between the radiologist and the clinician.
Germline genetic testing in prostate cancer — further enrichment in variant histologies? Oncoscience ; 5: 62— Inherited DNA-repair gene mutations in men with metastatic prostate cancer.
N Engl J Med. Eur Urol. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. J Clin Oncol.
The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer. Prostate cancer diagnosis journal analysis of three metastatic prostate cancer patients with exceptional responses to carboplatin indicating different types of DNA repair deficiency.
Prostate Cancer. Version 2. Mutations in BRCA2 and taxane resistance in prostate cancer.